Opthea

$13.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.27%) As of 4:32 PM UTC today

Why Robinhood?

You can buy or sell Opthea and other stocks, options, and ETFs commission-free!

About OPT

Opthea Limited American Depositary Shares, also called Opthea, is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia. The listed name for OPT is Opthea Limited American Depositary Shares.

CEO
Megan Baldwin
Employees
Headquarters
South Yarra, Victoria (VIC)
Founded
1984
Market Cap
553.56M
Price-Earnings Ratio
Dividend Yield
Average Volume
475.30
High Today
$13.15
Low Today
$13.06
Open Price
$13.15
Volume
1.60K
52 Week High
$13.85
52 Week Low
$10.49

Collections

You May Also Like